前沿论文｜CELL INTELLIGENCE

Programmable iPSC-derived CAR-NK vesicles remodel the immune microenvironment and eradicate tumors.

PubMed 2026/02/05 发表Cell Rep MedQ1 · IF 14（JCR 2025）

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy.

PubMed 2025/09/19 发表J Vis ExpQ3 · IF 1.2（JCR 2025）

CAR-exosomes derived from immune cells: an emerging nanoscale vanguard in overcoming tumor immunotherapy hurdles.

PubMed 2025/08/19 发表Front ImmunolQ1 · IF 7（JCR 2025）

Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach.

PubMed 2024/09/26 发表J Extracell BiolQ2 · IF 4.8（JCR 2025）

Breakthrough of solid tumor treatment: CAR-NK immunotherapy.

PubMed 2024/01/20 发表Cell Death DiscovQ1 · IF 10.4（JCR 2025）

Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art.

PubMed 2023/08/05 发表Cancer Cell IntQ1 · IF 7（JCR 2025）

Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment.

PubMed 2022/11/30 发表Int J Mol SciQ1 · IF 5.6（JCR 2025）

前沿论文 7